A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
ImmunityBio, Inc.
Merck Sharp & Dohme LLC
NuCana plc
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center